Both in Pharmaceuticals
CDT Equity vs Nexentis Technologies
Over the past year CDT returned −100.0% and NXTS returned −93.3%; their daily moves had a correlation of 0.77.
CDT −100.0% NXTS −93.3%Growth of $1, one year, split-adjusted
| Metric | CDT | NXTS |
|---|---|---|
| Price | $0.0423 | $0.4815 |
| Market cap | $32.6K | $699.8K |
| Today | −16.90% | −13.24% |
| 1 month | −94.9% | −55.4% |
| 6 months | −100.0% | — |
| Year to date | −100.0% | — |
| 1 year | −100.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | $8.5M |
| Dividend yield | — | — |
| Volatility (60d) | 991.2% | — |
| Short % of float | 18.8% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).